The Mumbai-based drug maker reported a net loss of Rs 136 crore in Q1FY25. Revenue rose 14% year-on-year (y-o-y) to Rs.747 crore in Q1FY25 compared to Rs.658 crore in Q4FY24.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
